Blockchain Registration Transaction Record

Triple Biomarker Test Reveals 3x Higher Heart Attack Risk

New research shows combining 3 blood tests—lipoprotein(a), remnant cholesterol & hsCRP—identifies people with 3x higher heart attack risk. Early detection could save lives.

This research matters because cardiovascular disease remains the leading cause of death globally, and current screening methods often miss people at high risk until it's too late. The combination of these three biomarkers—measuring genetic risk, cholesterol abnormalities, and inflammation—provides a more comprehensive assessment than traditional cholesterol tests alone. For individuals, this means potentially identifying heart disease risk years before symptoms appear, allowing for earlier lifestyle interventions and preventive treatments. For healthcare systems, it represents a cost-effective approach to targeted prevention that could reduce heart attack rates and healthcare costs. As these tests are already available in most labs, this research could quickly translate into clinical practice, helping doctors personalize prevention strategies and potentially saving countless lives through earlier detection of cardiovascular risk.